| myeloid cell differentiation | GO:0030099 | 86 | 0.336 | |
| positive regulation of cell cycle | GO:0045787 | 3 | 0.255 | |
| hemopoiesis | GO:0030097 | 183 | 0.241 | |
| organelle assembly | GO:0070925 | 110 | 0.220 | |
| cation transmembrane transport | GO:0098655 | 65 | 0.205 | |
| blood vessel development | GO:0001568 | 246 | 0.171 | |
| response to virus | GO:0009615 | 21 | 0.157 | |
| hormone biosynthetic process | GO:0042446 | 3 | 0.140 | |
| regulation of signal transduction | GO:0009966 | 225 | 0.139 | |
| determination of heart left right asymmetry | GO:0061371 | 117 | 0.121 | |
| response to stress | GO:0006950 | 263 | 0.120 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 107 | 0.113 | |
| vascular endothelial growth factor receptor signaling pathway | GO:0048010 | 13 | 0.110 | |
| vasculature development | GO:0001944 | 278 | 0.109 | |
| protein secretion | GO:0009306 | 1 | 0.108 | |
| organic substance biosynthetic process | GO:1901576 | 289 | 0.100 | |
| single organism organelle organization | GO:1902589 | 199 | 0.094 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 9 | 0.090 | |
| immune system development | GO:0002520 | 191 | 0.085 | |
| germ line stem cell division | GO:0042078 | 1 | 0.073 | |
| inorganic cation transmembrane transport | GO:0098662 | 50 | 0.072 | |
| signal transduction | GO:0007165 | 455 | 0.071 | |
| circadian sleep wake cycle sleep | GO:0050802 | 1 | 0.068 | |
| positive regulation of transport | GO:0051050 | 2 | 0.064 | |
| erythrocyte differentiation | GO:0030218 | 54 | 0.060 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 191 | 0.058 | |
| convergent extension | GO:0060026 | 118 | 0.056 | |
| response to external biotic stimulus | GO:0043207 | 97 | 0.056 | |
| cell surface receptor signaling pathway | GO:0007166 | 325 | 0.055 | |
| cellular macromolecule metabolic process | GO:0044260 | 391 | 0.054 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 1 | 0.054 | |
| erythrocyte homeostasis | GO:0034101 | 55 | 0.049 | |
| morphogenesis of an epithelium | GO:0002009 | 333 | 0.049 | |
| immune system process | GO:0002376 | 241 | 0.046 | |
| embryonic organ development | GO:0048568 | 381 | 0.046 | |
| regulation of muscle contraction | GO:0006937 | 3 | 0.042 | |
| convergent extension involved in organogenesis | GO:0060029 | 10 | 0.042 | |
| chordate embryonic development | GO:0043009 | 271 | 0.038 | |
| cellular nitrogen compound metabolic process | GO:0034641 | 290 | 0.038 | |
| myeloid cell development | GO:0061515 | 32 | 0.038 | |
| digestive tract development | GO:0048565 | 265 | 0.037 | |
| water homeostasis | GO:0030104 | 4 | 0.036 | |
| cell substrate adhesion | GO:0031589 | 4 | 0.036 | |
| determination of left right symmetry | GO:0007368 | 179 | 0.034 | |
| negative regulation of secretion | GO:0051048 | 2 | 0.034 | |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 4 | 0.034 | |
| inorganic ion transmembrane transport | GO:0098660 | 57 | 0.033 | |
| inner ear development | GO:0048839 | 126 | 0.033 | |
| ion transmembrane transport | GO:0034220 | 91 | 0.033 | |
| response to chemical | GO:0042221 | 320 | 0.032 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 2 | 0.032 | |
| regulation of lipase activity | GO:0060191 | 2 | 0.032 | |
| cellular component morphogenesis | GO:0032989 | 336 | 0.031 | |
| biosynthetic process | GO:0009058 | 294 | 0.031 | |
| positive regulation of phospholipase c activity | GO:0010863 | 1 | 0.030 | |
| single organism metabolic process | GO:0044710 | 217 | 0.030 | |
| skeletal system development | GO:0001501 | 181 | 0.029 | |
| negative regulation of secretion by cell | GO:1903531 | 2 | 0.029 | |
| cell cycle g1 s phase transition | GO:0044843 | 1 | 0.028 | |
| heterocycle biosynthetic process | GO:0018130 | 215 | 0.028 | |
| specification of symmetry | GO:0009799 | 204 | 0.028 | |
| autophagy | GO:0006914 | 4 | 0.028 | |
| kidney development | GO:0001822 | 92 | 0.028 | |
| positive regulation of signal transduction | GO:0009967 | 56 | 0.028 | |
| positive regulation of striated muscle cell differentiation | GO:0051155 | 1 | 0.027 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 1 | 0.027 | |
| regulation of endothelial cell proliferation | GO:0001936 | 1 | 0.026 | |
| cilium organization | GO:0044782 | 71 | 0.026 | |
| nucleic acid metabolic process | GO:0090304 | 244 | 0.025 | |
| cellular response to chemical stimulus | GO:0070887 | 157 | 0.025 | |
| bicarbonate transport | GO:0015701 | 4 | 0.025 | |
| somatic stem cell maintenance | GO:0035019 | 1 | 0.025 | |
| tube morphogenesis | GO:0035239 | 349 | 0.025 | |
| mesenchymal cell differentiation | GO:0048762 | 87 | 0.025 | |
| regulation of developmental process | GO:0050793 | 247 | 0.024 | |
| positive regulation of cell adhesion | GO:0045785 | 1 | 0.024 | |
| regulation of nitrogen compound metabolic process | GO:0051171 | 251 | 0.024 | |
| regulation of phospholipase activity | GO:0010517 | 2 | 0.024 | |
| oxidation reduction process | GO:0055114 | 41 | 0.024 | |
| energy reserve metabolic process | GO:0006112 | 2 | 0.024 | |
| response to biotic stimulus | GO:0009607 | 97 | 0.023 | |
| negative regulation of cellular process | GO:0048523 | 283 | 0.023 | |
| positive regulation of cell division | GO:0051781 | 2 | 0.023 | |
| aorta development | GO:0035904 | 4 | 0.023 | |
| response to decreased oxygen levels | GO:0036293 | 25 | 0.023 | |
| positive regulation of cellular process | GO:0048522 | 201 | 0.023 | |
| regulation of rna metabolic process | GO:0051252 | 224 | 0.023 | |
| regulation of nucleobase containing compound metabolic process | GO:0019219 | 250 | 0.023 | |
| cellular macromolecule biosynthetic process | GO:0034645 | 224 | 0.023 | |
| phototransduction visible light | GO:0007603 | 2 | 0.023 | |
| blood circulation | GO:0008015 | 87 | 0.022 | |
| nucleic acid templated transcription | GO:0097659 | 181 | 0.022 | |
| multicellular organismal homeostasis | GO:0048871 | 29 | 0.022 | |
| positive regulation of catabolic process | GO:0009896 | 4 | 0.022 | |
| regulation of reproductive process | GO:2000241 | 4 | 0.022 | |
| cellular response to growth factor stimulus | GO:0071363 | 39 | 0.022 | |
| regulation of hematopoietic progenitor cell differentiation | GO:1901532 | 1 | 0.022 | |
| smooth muscle contraction | GO:0006939 | 2 | 0.021 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 1 | 0.021 | |
| regulation of multicellular organism growth | GO:0040014 | 4 | 0.021 | |
| proteasomal protein catabolic process | GO:0010498 | 2 | 0.021 | |
| actin filament based process | GO:0030029 | 64 | 0.021 | |
| positive regulation of cell communication | GO:0010647 | 56 | 0.021 | |
| erk1 and erk2 cascade | GO:0070371 | 4 | 0.021 | |
| response to other organism | GO:0051707 | 97 | 0.021 | |
| cell projection organization | GO:0030030 | 284 | 0.021 | |
| circulatory system process | GO:0003013 | 87 | 0.020 | |
| determination of bilateral symmetry | GO:0009855 | 204 | 0.020 | |
| positive regulation of cytokine production | GO:0001819 | 2 | 0.020 | |
| regulation of membrane potential | GO:0042391 | 23 | 0.020 | |
| gene expression | GO:0010467 | 252 | 0.020 | |
| reflex | GO:0060004 | 2 | 0.019 | |
| central nervous system development | GO:0007417 | 387 | 0.019 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 1 | 0.019 | |
| endothelial cell proliferation | GO:0001935 | 11 | 0.019 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 3 | 0.019 | |
| regulation of growth rate | GO:0040009 | 1 | 0.019 | |
| muscle system process | GO:0003012 | 20 | 0.019 | |
| response to external stimulus | GO:0009605 | 264 | 0.018 | |
| antimicrobial humoral response | GO:0019730 | 2 | 0.018 | |
| system process | GO:0003008 | 185 | 0.018 | |
| regulation of heart growth | GO:0060420 | 2 | 0.018 | |
| membrane repolarization | GO:0086009 | 2 | 0.018 | |
| mitotic cytokinesis | GO:0000281 | 3 | 0.018 | |
| biological adhesion | GO:0022610 | 40 | 0.018 | |
| organelle organization | GO:0006996 | 227 | 0.018 | |
| nucleobase containing compound biosynthetic process | GO:0034654 | 205 | 0.018 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 106 | 0.018 | |
| regulation of dendrite development | GO:0050773 | 3 | 0.017 | |
| cellular protein metabolic process | GO:0044267 | 129 | 0.017 | |
| regulation of mitotic cell cycle | GO:0007346 | 25 | 0.017 | |
| cellular response to external stimulus | GO:0071496 | 2 | 0.017 | |
| phagocytosis | GO:0006909 | 3 | 0.017 | |
| regulation of immune system process | GO:0002682 | 34 | 0.017 | |
| growth | GO:0040007 | 174 | 0.017 | |
| negative regulation of gliogenesis | GO:0014014 | 1 | 0.017 | |
| positive regulation of lipid metabolic process | GO:0045834 | 1 | 0.017 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 4 | 0.017 | |
| cellular response to endogenous stimulus | GO:0071495 | 68 | 0.017 | |
| homeostatic process | GO:0042592 | 142 | 0.017 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 4 | 0.017 | |
| locomotor rhythm | GO:0045475 | 3 | 0.017 | |
| activation of immune response | GO:0002253 | 9 | 0.017 | |
| regulation of cytokine production | GO:0001817 | 3 | 0.017 | |
| regulation of cardiac muscle contraction | GO:0055117 | 2 | 0.017 | |
| cellular modified amino acid metabolic process | GO:0006575 | 3 | 0.016 | |
| regulation of cellular biosynthetic process | GO:0031326 | 245 | 0.016 | |
| protein modification process | GO:0036211 | 100 | 0.015 | |
| regulation of transcription dna templated | GO:0006355 | 213 | 0.015 | |
| positive regulation of stress activated protein kinase signaling cascade | GO:0070304 | 3 | 0.015 | |
| innate immune response activating signal transduction | GO:0002758 | 5 | 0.014 | |
| interspecies interaction between organisms | GO:0044419 | 4 | 0.014 | |
| transcription dna templated | GO:0006351 | 181 | 0.014 | |
| cellular response to organic substance | GO:0071310 | 105 | 0.014 | |
| osteoclast development | GO:0036035 | 1 | 0.014 | |
| regulation of gene expression | GO:0010468 | 265 | 0.014 | |
| regulation of cell communication | GO:0010646 | 232 | 0.014 | |
| sodium ion import | GO:0097369 | 3 | 0.014 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 3 | 0.014 | |
| positive regulation of map kinase activity | GO:0043406 | 3 | 0.014 | |
| regulation of cell activation | GO:0050865 | 1 | 0.014 | |
| peptide transport | GO:0015833 | 1 | 0.014 | |
| synaptic transmission cholinergic | GO:0007271 | 4 | 0.014 | |
| macroautophagy | GO:0016236 | 1 | 0.014 | |
| growth plate cartilage development | GO:0003417 | 2 | 0.014 | |
| protein polyubiquitination | GO:0000209 | 4 | 0.014 | |
| protein complex disassembly | GO:0043241 | 1 | 0.014 | |
| adult behavior | GO:0030534 | 2 | 0.014 | |
| fatty acid biosynthetic process | GO:0006633 | 4 | 0.013 | |
| cellular response to hypoxia | GO:0071456 | 1 | 0.013 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 42 | 0.013 | |
| positive regulation of macromolecule metabolic process | GO:0010604 | 93 | 0.013 | |
| cellular response to decreased oxygen levels | GO:0036294 | 1 | 0.013 | |
| digestive tract morphogenesis | GO:0048546 | 231 | 0.013 | |
| heart morphogenesis | GO:0003007 | 156 | 0.013 | |
| sodium ion transmembrane transport | GO:0035725 | 21 | 0.013 | |
| response to growth factor | GO:0070848 | 39 | 0.013 | |
| epidermal cell fate specification | GO:0009957 | 4 | 0.013 | |
| mitotic cell cycle | GO:0000278 | 64 | 0.013 | |
| regulation of biosynthetic process | GO:0009889 | 250 | 0.013 | |
| urogenital system development | GO:0001655 | 97 | 0.013 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 1 | 0.013 | |
| regulation of rna biosynthetic process | GO:2001141 | 213 | 0.013 | |
| osteoclast differentiation | GO:0030316 | 1 | 0.013 | |
| negative regulation of angiogenesis | GO:0016525 | 7 | 0.013 | |
| negative regulation of hormone secretion | GO:0046888 | 2 | 0.012 | |
| heart development | GO:0007507 | 313 | 0.012 | |
| phagocytosis engulfment | GO:0006911 | 1 | 0.012 | |
| heart contraction | GO:0060047 | 71 | 0.012 | |
| regulation of cellular component organization | GO:0051128 | 86 | 0.012 | |
| cellular amine metabolic process | GO:0044106 | 2 | 0.012 | |
| head development | GO:0060322 | 303 | 0.012 | |
| sequestering of metal ion | GO:0051238 | 3 | 0.012 | |
| negative regulation of programmed cell death | GO:0043069 | 58 | 0.012 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 4 | 0.012 | |
| regulation of circadian rhythm | GO:0042752 | 4 | 0.012 | |
| cellular protein modification process | GO:0006464 | 100 | 0.012 | |
| positive regulation of lipase activity | GO:0060193 | 1 | 0.012 | |
| response to hydrogen peroxide | GO:0042542 | 3 | 0.012 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 1 | 0.011 | |
| positive regulation of leukocyte chemotaxis | GO:0002690 | 1 | 0.011 | |
| histone modification | GO:0016570 | 20 | 0.011 | |
| epithelial tube morphogenesis | GO:0060562 | 148 | 0.011 | |
| platelet morphogenesis | GO:0036344 | 1 | 0.011 | |
| regulation of biological quality | GO:0065008 | 263 | 0.011 | |
| regulation of meiotic cell cycle | GO:0051445 | 1 | 0.011 | |
| muscle contraction | GO:0006936 | 18 | 0.011 | |
| nitric oxide biosynthetic process | GO:0006809 | 2 | 0.011 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 3 | 0.011 | |
| wnt signaling pathway | GO:0016055 | 80 | 0.011 | |
| macromolecule biosynthetic process | GO:0009059 | 227 | 0.011 | |
| cellular response to oxygen levels | GO:0071453 | 1 | 0.011 | |
| gtp catabolic process | GO:0006184 | 2 | 0.011 | |
| response to endogenous stimulus | GO:0009719 | 83 | 0.011 | |
| axon ensheathment in central nervous system | GO:0032291 | 2 | 0.011 | |
| erythrocyte development | GO:0048821 | 24 | 0.011 | |
| hard palate development | GO:0060022 | 4 | 0.011 | |
| organic cyclic compound biosynthetic process | GO:1901362 | 223 | 0.011 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 4 | 0.010 | |
| reciprocal meiotic recombination | GO:0007131 | 1 | 0.010 | |
| negative regulation of nitrogen compound metabolic process | GO:0051172 | 59 | 0.010 | |
| positive regulation of i kappab kinase nf kappab signaling | GO:0043123 | 3 | 0.010 | |
| regulation of autophagy | GO:0010506 | 3 | 0.010 | |
| macromolecular complex disassembly | GO:0032984 | 1 | 0.010 | |
| cellular biosynthetic process | GO:0044249 | 286 | 0.010 | |
| regulation of cardiac muscle cell contraction | GO:0086004 | 1 | 0.010 | |
| regulation of cellular macromolecule biosynthetic process | GO:2000112 | 222 | 0.010 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 50 | 0.010 | |
| long chain fatty acid metabolic process | GO:0001676 | 1 | 0.010 | |
| blood vessel morphogenesis | GO:0048514 | 216 | 0.010 | |
| positive regulation of translation | GO:0045727 | 1 | 0.010 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 2 | 0.010 | |
| actin cytoskeleton organization | GO:0030036 | 63 | 0.010 | |
| lipid catabolic process | GO:0016042 | 4 | 0.010 | |
| response to nutrient | GO:0007584 | 3 | 0.010 | |
| amine metabolic process | GO:0009308 | 2 | 0.010 | |
| negative regulation of mapk cascade | GO:0043409 | 4 | 0.010 | |
| embryonic heart tube development | GO:0035050 | 133 | 0.010 | |
